Low cholesterol triggers membrane microdomain-dependent CD44 shedding and suppresses tumor cell migration

Area of Science:

• Cell Biology
• Molecular Oncology
• Biochemistry

Background:

• CD44, a cell surface molecule binding hyaluronan, is crucial for tumor invasion and metastasis.
• Proteolytic cleavage of CD44, regulated by the tumor microenvironment, drives tumor cell migration.
• The molecular mechanisms of CD44 proteolytic cleavage at the cell membrane are not fully understood.

Purpose of the Study:

• To investigate the role of membrane lipid organization in CD44 shedding.
• To explore the molecular mechanisms of CD44 cleavage, particularly concerning cholesterol and lipid rafts.
• To evaluate the potential of cholesterol reduction strategies in modulating CD44 shedding and tumor cell migration.

Main Methods:

• Cholesterol depletion using methyl-β-cyclodextrin to disrupt membrane lipid rafts.
• Assessment of CD44 shedding mediated by a disintegrin and metalloproteinase 10 (ADAM10).
• Long-term cholesterol reduction using a statin agent.
• Evaluation of tumor cell migration on a hyaluronan-coated substrate.

Main Results:

• Cholesterol depletion enhances CD44 shedding, mediated by ADAM10, and disrupts CD44 localization to lipid rafts.
• Long-term cholesterol reduction with statins also enhances CD44 shedding.
• Statin treatment suppresses tumor cell migration on hyaluronan-coated substrates.

Conclusions:

• Membrane lipid organization, specifically cholesterol content, regulates CD44 shedding.
• Cholesterol reduction may offer a therapeutic strategy for preventing and treating malignant tumor progression.
• The findings propose a molecular mechanism involving cholesterol reduction's effect on CD44 shedding and tumor cell behavior.